gold arrow pointing upward forward
Biotech

Protara shares spike after bladder cancer data drop

Protara’s cell therapy elicited a 72% complete response rate for patients with bladder cancer, data that sent the biotech’s shares surging.
Gabrielle Masson Dec 5, 2024 2:30pm
pivot change turnaround direction walk away

AstraZeneca, Daiichi share data behind Dato-DXd do-over

Dec 6, 2024 5:21am
heart art heart failure genes

Cleerly collects $106M for its coronary artery scanning AI

Dec 5, 2024 2:50pm
Law symbols composition

Insulet nets $452M in EOFlow insulin pump trade secrets suit

Dec 5, 2024 12:00pm
Upside-down hourglass

RANKL cytokine makes the thymus more youthful in mice

Dec 5, 2024 11:45am
invest benjamin franklin dollars bills

Fierce Biotech Fundraising Tracker: Nuvig, Antag & more

Dec 5, 2024 10:00am
Medtech News

Zimmer Biomet's cement-alternative knee implants collect FDA OKs

Dec 4, 2024 11:30am

Philips, Mayo Clinic team up on AI for cardiac MRI scans

Dec 3, 2024 1:30pm

Siemens Healthineers debuts automated abdomen ultrasound AI

Dec 3, 2024 12:00pm

BMS taps AI Proteins in drug discovery collab worth up to $400M

Dec 3, 2024 10:45am